184
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

In-Vitro Analysis of Glucose and Quercetin Effects on m-TOR and Nrf-2 Expression in HepG2 Cell Line (Diabetes and Cancer Connection)

, , &
Pages 770-775 | Received 22 Aug 2017, Accepted 17 Feb 2018, Published online: 21 May 2018

References

  • Vigneri P, Frasca F, Sciacca L, Pandini G, and Vigneri R: Diabetes and cancer. Endocr Relat Cancer 16(4), 1103–1123, 2009.
  • Niwa Y, Ishikawa K, Ishigami M, Honda T, Achiwa K, et al.: Effect of hyperglycemia on hepatocellular carcinoma development in diabetes. Biochem Biophys Res Commun 463(3), 344–350, 2015.
  • Chandrasekaran K, Swaminathan K, Chatterjee S, and Dey A: Apoptosis in HepG2 cells exposed to high glucose. Toxicol In Vitro 24(2), 387–396, 2010.
  • Zal F, Jafarian A, Hajizadeh MR, Safaei A, Miri R, et al.: Effects of walnut male flower extract on islet regeneration and glucokinase activity. Diabetes Stoffwech H 22(5), 283–287, 2013.
  • Miladpour B, Rasti M, Owji AA, Mostafavipour Z, Khoshdel Z, et al.: Quercetin potentiates transdifferentiation of bone marrow mesenchymal stem cells into the beta cells in vitro. J Endocrinol Invest 40(5), 513–521, 2017. doi:10.1007/s40618-016-0592-8.
  • Zal F, Taheri R, Khademi F, Keshavarz E, Rajabi S, et al.: The combined effect of furosemide and propranolol on GSH homeostasis in ACHN renal cells. Toxicol Mech Methods 24(6), 412–416, 2014. doi:10.3109/15376516.2014.926437.
  • Ceriello A, Dello Russo P, Amstad P, and Cerutti P: High glucose induces antioxidant enzymes in human endothelial cells in culture: evidence linking hyperglycemia and oxidative stress. Diabetes 45(4), 471–477, 1996.
  • Rodriguez-Brotons A, Bietiger W, Peronet C, Langlois A, Magisson J, et al.: Comparison of perfluorodecalin and HEMOXCell as oxygen carriers for islet oxygenation in an in vitro model of encapsulation. Tissue Eng Part A 22(23–24), 1327–1336, 2016. doi:10.1089/ten.tea.2016.0064.
  • Eggler AL, Gay KA, and Mesecar AD: Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2. Mol Nutr Food Res 52(S1), S84–S94, 2008.
  • Mostafavi-Pour Z, Ramezani F, Keshavarzi F, and Samadi N: The role of quercetin and vitamin C in Nrf2-dependent oxidative stress production in breast cancer cells. Oncol Lett 13(3), 1965–1973, 1899. doi:10.3892/ol.2017.5619.
  • Granado-Serrano AB, Martín MA, Bravo L, Goya L, and Ramos S: Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: involvement of p38. Chem Biol Interact 195(2), 154–164, 2012.
  • Passtoors WM, Beekman M, Deelen J, van der Breggen R, Maier AB, et al.: Gene expression analysis of mTOR pathway: association with human longevity. Aging Cell 12(1), 24–31, 2013.
  • Laplante M and Sabatini DM: mTOR signaling in growth control and disease. Cell 149(2), 274–293, 2012.
  • Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, et al.: Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279(29), 30369–30374, 2004.
  • Sampson L, Rimm E, Hollman PC, de VRIES JH, and Katan MB: Flavonol and flavone intakes in US health professionals. J Am Diet Assoc 102(10), 1414–1420, 2002.
  • Pour ZM, Vessal M, Zal F, Khoshdel Z, and Torabinejad S: Protective effects of vitamin E and/or quercetin co-supplementation on the morphology of kidney in cyclosporine A-treated rats. Iran J Med Sci 34(4), 271–276, 2015.
  • Miladpour B, Rasti M, Owji A, Mostafavipour Z, Khoshdel Z, et al.: Quercetin potentiates transdifferentiation of bone marrow mesenchymal stem cells into the beta cells in vitro. J Endocrinol Invest 40(5), 513–521, 2017.
  • Mostafavi-Pour Z, Khademi F, Zal F, Sardarian AR, and Amini F: In vitro analysis of CsA-induced hepatotoxicity in HepG2 cell line: oxidative stress and alpha2 and beta1 integrin subunits expression. Hepat Mon 13(8), e11447, 2013. doi:10.5812/hepatmon.11447.
  • Yarahmadi A, Zal F, and Bolouki A: Protective effects of quercetin on nicotine induced oxidative stress in ‘HepG2 cells’. Toxicol Mech Methods 27(8), 609–614, 2017. doi:10.1080/15376516.2017.1344338.
  • Ramezani F, Samadi N, and Mostafavi-Pour Z: Sequential therapy of breast cancer cell lines with vitamin C and quercetin improves the efficacy of chemotherapeutic drugs. Nutr Cancer 69(6), 881–891, 2017. doi:10.1080/01635581.2017.1339813.
  • Ryu JM, Lee MY, Yun SP, and Han HJ: High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF-β1 expression via Ca2+/PKC/MAPKs and PI3K/Akt/mTOR signal pathways. J Cell Physiol 224(1), 59–70, 2010.
  • Zou Y-X, Shen W-Z, Liao S-T, Liu F, Zheng S-Q, et al.: Mulberry leaf phenolics ameliorate hyperglycemia-induced oxidative stress and stabilize mitochondrial membrane potential in HepG2 cells. Int J Food Sci Nutr 65(8), 960–966, 2014.
  • Mittal SP, Khole S, Jagadish N, Ghosh D, Gadgil V, et al.: Andrographolide protects liver cells from H2O2 induced cell death by upregulation of Nrf-2/HO-1 mediated via adenosine A 2a receptor signalling. Biochimica et Biophysica Acta (BBA)-Gen Subj 1860(11), 2377–2390, 2016. doi:10.1016/j.bbagen.2016.07.005.
  • Wang X, Feng Z, Li J, Chen L, and Tang W: High glucose induces autophagy of MC3T3-E1 cells via ROS-AKT-mTOR axis. Mol Cell Endocrinol 429, 62–72, 2016.
  • Sahin F, Kannangai R, Adegbola O, Wang J, Su G, et al.: mTOR and P70 S6 kinase expression in primary liver neoplasms. Clin Cancer Res 10(24), 8421–8425, 2004.
  • Chan S: Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer. Br J Cancer 91(8), 1420–1424, 2004.
  • Yu K, Toral-Barza L, Discafani C, Zhang W, Skotnicki J, et al.: mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr Relat Cancer 8(3), 249–258, 2001.
  • Vigneron F, Dos Santos P, Lemoine S, Bonnet M, Tariosse L, et al.: GSK-3beta at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways. Cardiovasc Res 90(1), 49–56, 2011. doi:10.1093/cvr/cvr002.
  • Chen L, Xu B, Liu L, Luo Y, Yin J, et al.: Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells. Lab Invest 90(5), 762–73, 2010. doi:10.1038/labinvest.2010.36.
  • Murakami A, Ashida H, and Terao J: Multitargeted cancer prevention by quercetin. Cancer Lett 269(2), 315–25, 2008.
  • Alam MM, Meerza D, and Naseem I: Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci 109(1), 8–14, 2014.
  • Klappan AK, Hones S, Mylonas I, and Brüning A: Proteasome inhibition by quercetin triggers macroautophagy and blocks mTOR activity. Histochem Cell Biol 137(1), 25–36, 2012.
  • Lu Q, Ji X-J, Zhou Y-X, Yao X-Q, Liu Y-Q, et al.: Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial–mesenchymal transition and renal fibrosis in diabetic nephropathy. Pharmacol Res 99, 237–247, 2015.
  • Boots AW, Haenen GR, and Bast A: Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585(2), 325–337, 2008.
  • Coskun O, Kanter M, Korkmaz A, and Oter S: Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res 51(2), 117–123, 2005.
  • Li H, Wang F, Zhang L, Cao Y, Liu W, et al.: Modulation of Nrf2 expression alters high glucose-induced oxidative stress and antioxidant gene expression in mouse mesangial cells. Cell Signal 23(10), 1625–1632, 2011.
  • Ungvari Z, Bailey-Downs L, Gautam T, Jimenez R, Losonczy G, et al.: Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Am J Physiol Heart Circ Physiol 300(4), H1133–H40, 2011. doi:10.1152/ajpheart.00402.2010.
  • Wang C, Li C, Peng H, Ye Z, Zhang J, et al.: Activation of the Nrf2-ARE pathway attenuates hyperglycemia-mediated injuries in mouse podocytes. Cell Physiol Biochem 34(3), 891–902, 2014.
  • Negi G, Kumar A, Joshi RP, and Sharma SS: Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem Biophys Res Commun 408(1), 1–5, 2011.
  • Braun S, Hanselmann C, Gassmann MG, auf dem Keller U, Born-Berclaz C, et al.: Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol Cell Biol 22(15), 5492–5505, 2002.
  • Jiménez-Aliaga K, Bermejo-Bescós P, Benedí J, and Martín-Aragón S: Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. Life Sci 89(25), 939–945, 2011.
  • Petrelli A, Perra A, Cora D, Sulas P, Menegon S, et al.: MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). Hepatology 59(1), 228–41, 2014.
  • Hayes JD and McMahon M: NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 34(4), 176–188, 2009.
  • Gibellini L, Pinti M, Nasi M, Montagna JP, De Biasi S, et al.: Quercetin and cancer chemoprevention. Evidence-Based Complement Altern Med 2011, 591356, 2011. doi:10.1093/ecam/neq053.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.